BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Vitali M, Bertuzzo F, De Angelis M, Mantovani G, Iacono C. Hepatocellular carcinoma: Surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol 2014; 20(24): 7525-7533 [PMID: 24976693 DOI: 10.3748/wjg.v20.i24.7525]
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7525.htm
Number Citing Articles
1
Chong Wang, Lei Yang, Zikun Liang, Yaodong Liu, Shuku Liu. Long‐Term Survival and Prognostic Factors of Pulmonary Metastasectomy in Liver Cancer: A Systematic Review and Meta‐AnalysisWorld Journal of Surgery 2018; 42(7): 2153 doi: 10.1007/s00268-017-4431-7
2
Fan Yang, Le Shi, Tao Liang, Leilei Ji, Guangji Zhang, Yang Shen, Fangfang Zhu, Li Xu. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinomaBiochemical and Biophysical Research Communications 2017; 485(1): 54 doi: 10.1016/j.bbrc.2017.02.017
3
Mikael H. Sodergren, Dinesh Sharma. Liver Cancers2019; : 83 doi: 10.1007/978-3-319-92216-4_7
4
Lifang Ma, Qiuhui Pan, Fenyong Sun, Yongchun Yu, Jiayi Wang. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-κB in liver cancer cell line Bel-7402Biochemical and Biophysical Research Communications 2014; 451(2): 334 doi: 10.1016/j.bbrc.2014.07.128
5
Eduard Jonas, Marc Bernon, Barbara Robertson, Chris Kassianides, Elie Keli, Kwaku Offei Asare, Isaac Olusegun Alatise, Michael Okello, Nana Oumarou Blondel, Kenedy Ondede Mulehane, Zeki Abdurahman Abubeker, Alaaeldin Awad Nogoud, Pueya Rashid Nashidengo, Onesai Chihaka, Christian Tzeuton, Geoffrey Dusheiko, Mark Sonderup, C Wendy Spearman. Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutionsThe Lancet Gastroenterology & Hepatology 2022; 7(11): 1049 doi: 10.1016/S2468-1253(22)00042-5
6
Ying Ma, Ming Ma, Ling Ma, Fengbo Zhang, Yumei Liu, Xiumin Ma. Downregulation of miR‑552 in hepatocellular carcinoma inhibits cell migration and invasion, and promotes cell apoptosis via RUNX3Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.8061
7
Davide Roccarina, Avik Majumdar, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with intermediate-stage hepatocellular carcinomaCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011649.pub2
8
Chiuyen Phan, Ziyang Zheng, Jianwei Wang, Qiwen Wang, Xiurong Hu, Guping Tang, Hongzhen Bai. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complexBiomaterials Science 2019; 7(11): 4758 doi: 10.1039/C9BM01190K
9
Saneya Pandrowala, Shraddha Patkar, Mahesh Goel, Darius Mirza, S. K. Mathur. Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithmLangenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02881-w
10
CHANGHE ZHANG, XIAOFEI CAO, YONGXIANG GEI, YONG WANG, GUIYUAN LIU, GUOCHANG CHENG, QINGHONG LIU. Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cellsOncology Letters 2015; 10(3): 1627 doi: 10.3892/ol.2015.3451
11
Yao-Li Chen, Shih-Hsuan Chan, Ping-Yi Lin, Pei-Yi Chu. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patientsHuman Pathology 2017; 63: 212 doi: 10.1016/j.humpath.2017.03.003
12
Wang Yuhuang, Li Kang, Bai Chen, Feng Guodong, Zhang Xiuming, Shi Dan, Zhang Yu, Liu Nianlong. The application of magnetic resonance ultrasmall magnetic Fe3O4 nano bimodal contrast agent in rabbit orthotopic liver tumorsPrecision Medical Sciences 2022; 11(3): 130 doi: 10.1002/prm2.12078
13
Tian Yang, Wan-Yee Lau, Han Zhang, Bin Huang, Jun-Hua Lu, Meng-Chao Wu. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons’ perspectiveWorld Journal of Gastroenterology 2015; 21(27): 8256-8261 doi: 10.3748/wjg.v21.i27.8256
14
A Lei Feng, Jian Kang Zhu, Yupeng Yang, Ya Dong Wang, Feng Yue Liu, Min Zhu, Chong Zhong Liu. Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCCMinimally Invasive Therapy & Allied Technologies 2021; 30(3): 163 doi: 10.1080/13645706.2019.1707689
15
Sonia T. Orcutt, Daniel A. Anaya. Liver Resection and Surgical Strategies for Management of Primary Liver CancerCancer Control 2018; 25(1): 107327481774462 doi: 10.1177/1073274817744621
16
Sandeep Arora, Carla Harmath, Roberta Catania, Ari Mandler, Kathryn J. Fowler, Amir A. Borhani. Hepatocellular carcinoma: metastatic pathways and extra-hepatic findingsAbdominal Radiology 2021; 46(8): 3698 doi: 10.1007/s00261-021-03151-3
17
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectivesExpert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
18
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systemsPLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
19
Jin‐Yu Sun, Tailang Yin, Xiao‐Yu Zhang, Xiao‐Jie Lu. Therapeutic advances for patients with intermediate hepatocellular carcinomaJournal of Cellular Physiology 2019; 234(8): 12116 doi: 10.1002/jcp.28019
20
CHENG-ZUO XIAO, WEI WEI, ZHI-XING GUO, SHU-HONG LI, YONG-FA ZHANG, JIA-HONG WANG, MING SHI, RONG-PING GUO. A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resectionOncology Letters 2015; 10(5): 2787 doi: 10.3892/ol.2015.3677
21
Jae Ho Sohn, Rafael Duran, Yan Zhao, Florian Fleckenstein, Julius Chapiro, Sonia Sahu, Rüdiger E. Schernthaner, Tianchen Qian, Howard Lee, Li Zhao, James Hamilton, Constantine Frangakis, MingDe Lin, Riad Salem, Jean-Francois Geschwind. Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial TherapyClinical Gastroenterology and Hepatology 2017; 15(5): 746 doi: 10.1016/j.cgh.2016.10.036
22
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
23
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factorsMedicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
24
Osama M. Elsanousi, Murtada A. Mohamed, Fatima H. Salim, Elsadig A. Adam, Shahinaz Bedri. Long-term outcome of novel combined surgical-injection treatment (COSIT) for large hepatocellular carcinoma: Stage 2A IDEAL prospective case seriesAnnals of Medicine and Surgery 2021; 72: 103098 doi: 10.1016/j.amsu.2021.103098
25
Yutao Yuan, Fangnian Yang, Yuanyuan Wang, Yusong Guo. Factors associated with liver cancer prognosis after hepatectomyMedicine 2021; 100(42): e27378 doi: 10.1097/MD.0000000000027378
26
Jiang-feng Xu, Xi-yu Liu, Shuai Wang, Huai-xi Wen. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classificationWorld Journal of Surgical Oncology 2015; 13(1): 86 doi: 10.1186/s12957-015-0493-x
27
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinomaThe Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
28
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews2015;  doi: 10.1002/14651858.CD011649
29
Eloy Ruiz, Teresa Rojas Rojas, Francisco Berrospi, Ivan Chávez, Carlos Luque, Luis Cano, Franco Doimi, Pascal Pineau, Eric Deharo, Stéphane Bertani. Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of PeruHeliyon 2016; 2(1): e00052 doi: 10.1016/j.heliyon.2015.e00052
30
Maria Baimas-George, Christoph Tschuor, Michael Watson, Jesse Sulzer, Patrick Salibi, David Iannitti, John B. Martinie, Erin Baker, Pierre-Alain Clavien, Dionisios Vrochides. Current trends in vena cava reconstructive techniques with major liver resection: a systematic reviewLangenbeck's Archives of Surgery 2021; 406(1): 25 doi: 10.1007/s00423-020-01989-7
31
Jianchu Wang, Zongjiang Luo, Tianwei Yao, Wenchuan Li, Jian Pu. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathwayJournal of Cellular Physiology 2019; 234(5): 6908 doi: 10.1002/jcp.27449
32
Chung-Lin Hung, Chia-Shen Yen, Hung-Wen Tsai, Yu-Chieh Su, Chia-Jui Yen. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal diseaseBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1671-5
33
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and howWorld Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
34
Jill Gwiasda, Aron Schulte, Alexander Kaltenborn, Wolf Ramackers, Moritz Kleine, Oliver Beetz, Jürgen Klempnauer, Nikos Emmanouilidis, Harald Schrem. Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinomaSurgical Oncology 2017; 26(2): 178 doi: 10.1016/j.suronc.2017.03.004
35
Ru‑Ting Xie, Xian‑Ling Cong, Xiao‑Ming Zhong, Ping Luo, Hui‑Qiong Yang, Gai‑Xia Lu, Pei Luo, Zheng‑Yan Chang, Ran Sun, Ting‑Miao Wu, Zhong‑Wei Lv, Da Fu, Yu‑Shui Ma. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinomaOncology Letters 2018;  doi: 10.3892/ol.2018.7892
36
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]2019;  doi: 10.5772/intechopen.86638
37
Fangfang Liang, Fuchao Ma, Jincai Zhong. Prognostic factors of patients after liver cancer surgeryMedicine 2021; 100(30): e26694 doi: 10.1097/MD.0000000000026694
38
Guoyong Chen, Jiabin Zhang, Jianjun Sun, Sidong Wei, Jianbin Chen, Hui Ren, Shaotang Zhou. Revisiting Partial Hepatectomy of Large Hepatocellular Carcinoma in Older PatientsScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32798-0
39
Jan Erik Slotta, Otto Kollmar, Volker Ellenrieder, B Michael Ghadimi, Kia Homayounfar. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectivesWorld Journal of Hepatology 2015; 7(9): 1168-1183 doi: 10.4254/wjh.v7.i9.1168
40
Yi‐Chia Chan, Catherine S. Kabiling, Vinod G. Pillai, Gustavo Aguilar, Chih‐Chi Wang, Chao‐Long Chen. Survival Outcome Between Hepatic Resection and Transarterial Embolization for Hepatocellular Carcinoma More Than 10 cm: A Propensity Score ModelWorld Journal of Surgery 2015; 39(6): 1510 doi: 10.1007/s00268-015-2975-y
41
Shraddha Patkar, Amir Parray, Balu Mahendra, Sagar Kurunkar, Mahesh Goel. Performance of Hong Kong Liver Cancer staging system in patients of hepatocellular carcinoma treated with surgical resection: An Indian validation studyJournal of Surgical Oncology 2019; 120(7): 1119 doi: 10.1002/jso.25704
42
Kenji Wakayama, Toshiya Kamiyama, Hideki Yokoo, Tatsuya Orimo, Shingo Shimada, Takahiro Einama, Hirofumi Kamachi, Akinobu Taketomi. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resectionJournal of Surgical Oncology 2017; 115(3): 324 doi: 10.1002/jso.24501
43
SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi. Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinomaSaudi Journal of Gastroenterology 2020; 26(7): 1 doi: 10.4103/sjg.SJG_477_20
44
Pasquale Zizza, Chiara Cingolani, Simona Artuso, Erica Salvati, Angela Rizzo, Carmen D'Angelo, Manuela Porru, Bruno Pagano, Jussara Amato, Antonio Randazzo, Ettore Novellino, Antonella Stoppacciaro, Eric Gilson, Giorgio Stassi, Carlo Leonetti, Annamaria Biroccio. Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevanceNucleic Acids Research 2016; 44(4): 1579 doi: 10.1093/nar/gkv1122
45
Dan-Yun Ruan, Ze-Xiao Lin, Tian-Tian Wang, Hui Zhao, Dong-Hao Wu, Jie Chen, Min Dong, Qu Lin, Xiang-Yuan Wu, Yang Li. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1Oncotarget 2016; 7(38): 61378 doi: 10.18632/oncotarget.11358